Clinical characteristics and outcomes of Richter transformation: Experience of 204 patients from a single center.
The natural history, prognostication and optimal treatment of Richter transformation developed from chronic lymphocytic leukemia (CLL) are not well defined. We report the clinical characteristics and outcomes of a large series of biopsy-confirmed Richter transformation (diffuse large B-cell lymphoma or high grade B-cell lymphoma, n=204) cases diagnosed from 1993 to 2018. After a median follow-up of 67.0 months, the median overall survival was 12.0 months. Patients who received no prior CLL treatment had significantly better overall survival (median 46.3 vs 7.8 months, P<0.001). Patients with elevated lactate dehydrogenase (median 6.2 vs 39.9 months, P<0.0001) or TP53 disruption (median 8.3 vs 12.8 months, P=0.046) had worse overall survival than those without. IGHV mutation, cell of origin, Myc/Bcl-2 double expression and MYC/BCL2/BCL6 double-/triple-hit status were not associated with overall survival. In multivariable Cox regression, elevated lactate dehydrogenase (hazard ratio 2.3, 95% confidence interval 1.3-4.1; P=0.01), prior CLL treatment (hazard ratio 2.0, 95% confidence interval 1.2-3.5; P=0.01), and older age (hazard ratio 1.03, 95% confidence interval 1.01-1.05; P=0.01) were associated with worse overall survival. Twenty-four (12%) patients underwent stem cell transplant (20 autologous and 4 allogeneic), and had a median post-transplant survival of 55.4 months. In conclusion, the overall outcome of Richter transformation is poor. Richter transformation developed in untreated CLL patients has significantly better survival. Stem cell transplant may benefit select patients.